首页|期刊导航|国际肝胆健康（英文）|Efficacy analysis of hepatic arterial infusion chemotherapy combined with sintilimab and bevacizumab for initially unresectable hepatocellular carcinoma

Efficacy analysis of hepatic arterial infusion chemotherapy combined with sintilimab and bevacizumab for initially unresectable hepatocellular carcinoma

Zhu Chen Xingyu Chen Haiyang Hu Kai Chen Chengyou Du Heng Xiao Xiang Lan

国际肝胆健康（英文）Issue(2)：12-17,6.

国际肝胆健康（英文）Issue(2)：12-17,6.DOI:10.1016/j.iliver.2025.100163

Efficacy analysis of hepatic arterial infusion chemotherapy combined with sintilimab and bevacizumab for initially unresectable hepatocellular carcinoma

Zhu Chen ¹Xingyu Chen ¹Haiyang Hu ¹Kai Chen ¹Chengyou Du ¹Heng Xiao ¹Xiang Lan¹

作者信息

1. Department of Hepatobiliary Surgery,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China
折叠

摘要

关键词

Hepatocellular carcinoma/Hepatic arterial infusion chemotherapy/Sintilimab/Bevacizumab/Conversion therapy

Key words

Hepatocellular carcinoma/Hepatic arterial infusion chemotherapy/Sintilimab/Bevacizumab/Conversion therapy

引用本文复制引用

Zhu Chen,Xingyu Chen,Haiyang Hu,Kai Chen,Chengyou Du,Heng Xiao,Xiang Lan..Efficacy analysis of hepatic arterial infusion chemotherapy combined with sintilimab and bevacizumab for initially unresectable hepatocellular carcinoma[J].国际肝胆健康（英文）,2025,(2):12-17,6.

基金项目

This research was funded by the General Project of the Natural Science Foundation of Chongqing(cstc2021jcyj-msxmX0604)and the Chongqing Doctoral"Through Train"Research Program(CSTB2022BSXM-JCX0045). （cstc2021jcyj-msxmX0604）

国际肝胆健康（英文）

访问量2

下载量0

段落导航